T. Rowe Price Innovation Leaders ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: --
資產淨值: 27.56
成立日期: 28/01/2026
 
分析
市值分佈:
94.78%
大市值
2.62%
中市值
0.90%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:08) 總持有投資項目: 250  
0%
 
100%
     10大 (34.06%)
代號 名稱 佔比% ▼ 持有日期
PRAXPraxis Precision Medicines0.0931/10/2026
SGPSpyGlass Pharma Inc0.0931/10/2026
EUXTFEuronext NV0.0831/10/2026
ICLRICON plc0.0831/10/2026
CBRSCerebras Systems Inc.0.0831/10/2026
LNVGFLenovo Group Ltd.0.0831/10/2026
BRKRBruker Corp0.0831/10/2026
PBLSParabilis Medicines Inc0.0831/07/2026
CSGPCoStar Group0.0831/10/2026
GENBGenerate Biomedicines, Inc.0.0831/10/2026
CMPSCOMPASS Pathways Plc0.0831/10/2026
RYTMRhythm Pharmaceuticals0.0831/10/2026
PHVSPharvaris NV0.0831/10/2026
TSEMTower Semiconductor Ltd0.0731/10/2026
JBIOJade Biosciences Inc0.0731/10/2026
PACBPacific Biosciences of California0.0731/10/2026
IMNMImmunome0.0731/10/2026
AXSMAxsome Therapeutics0.0731/10/2026
RAPPRapport Therapeutics Inc.0.0731/10/2026
EFXEquifax0.0730/09/2026
  1    2    3    4    5    6    7    8    9    10   11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.